نتایج جستجو برای: mrd

تعداد نتایج: 1567  

Journal: :Blood 2011
Martin Schrappe Maria Grazia Valsecchi Claus R Bartram André Schrauder Renate Panzer-Grümayer Anja Möricke Rosanna Parasole Martin Zimmermann Michael Dworzak Barbara Buldini Alfred Reiter Giuseppe Basso Thomas Klingebiel Chiara Messina Richard Ratei Giovanni Cazzaniga Rolf Koehler Franco Locatelli Beat W Schäfer Maurizio Aricò Karl Welte Jacques J M van Dongen Helmut Gadner Andrea Biondi Valentino Conter

The prognostic value of MRD in large series of childhood T-ALL has not yet been established. Trial AIEOP-BFM-ALL 2000 introduced standardized quantitative assessment of MRD for stratification, based on immunoglobulin and TCR gene rearrangements as polymerase chain reaction targets: Patients were considered MRD standard risk (MRD-SR) if MRD was negative at day 33 (time point 1 [TP1]) and day 78 ...

Journal: :Blood 2007
Alida Dominietto Sarah Pozzi Maurizio Miglino Flavio Albarracin Giovanna Piaggio Francesca Bertolotti Raffaella Grasso Simona Zupo Anna Maria Raiola Marco Gobbi Francesco Frassoni Andrea Bacigalupo

Andrea Bacigalupo Alida Dominietto Sarah Pozzi Maurizio Miglino Flavio Albarracin Giovanna Piaggio Francesca Bertolotti Minimal residual disease (MRD) was monitored in 80 patients with acute lymphoid (ALL, n=44) or myeloid (AML, n=36) leukemia, undergoing allogeneic haemopoietic stem cell transplantations. MRD markers were IgH-VDJ and TCR gene rearrangement for ALL, and Wilm's Tumor (WT1) expre...

2016
Małgorzata Dawidowska Maria Kosmalska Łukasz Sędek Aleksandra Szczepankiewicz Magdalena Twardoch Alicja Sonsala Bronisława Szarzyńska-Zawadzka Katarzyna Derwich Monika Lejman Katarzyna Pawelec Agnieszka Obitko-Płudowska Katarzyna Pawińska-Wąsikowska Kinga Kwiecińska Andrzej Kołtan Agnieszka Dyla Władysław Grzeszczak Jerzy R. Kowalczyk Tomasz Szczepański Ewa Ziętkiewicz Michał Witt

Minimal residual disease (MRD) enables reliable assessment of risk in acute lymphoblastic leukemia (ALL). However, little is known on association between MRD status and germline genetic variation. We examined 159 Caucasian (Slavic) patients with pediatric ALL, treated according to ALL-IC-BFM 2002/2009 protocols, in search for association between 23 germline polymorphisms and MRD status at day 1...

Journal: :Blood 2015
Michael J Borowitz Brent L Wood Meenakshi Devidas Mignon L Loh Elizabeth A Raetz Wanda L Salzer James B Nachman Andrew J Carroll Nyla A Heerema Julie M Gastier-Foster Cheryl L Willman Yunfeng Dai Naomi J Winick Stephen P Hunger William L Carroll Eric Larsen

Minimal residual disease (MRD) is highly prognostic in pediatric B-precursor acute lymphoblastic leukemia (B-ALL). In Children's Oncology Group high-risk B-ALL study AALL0232, we investigated MRD in subjects randomized in a 2 × 2 factorial design to receive either high-dose methotrexate (HD-MTX) or Capizzi methotrexate (C-MTX) during interim maintenance (IM) or prednisone or dexamethasone durin...

Journal: :Blood 2010
Valentino Conter Claus R Bartram Maria Grazia Valsecchi André Schrauder Renate Panzer-Grümayer Anja Möricke Maurizio Aricò Martin Zimmermann Georg Mann Giulio De Rossi Martin Stanulla Franco Locatelli Giuseppe Basso Felix Niggli Elena Barisone Günter Henze Wolf-Dieter Ludwig Oskar A Haas Giovanni Cazzaniga Rolf Koehler Daniela Silvestri Jutta Bradtke Rosanna Parasole Rita Beier Jacques J M van Dongen Andrea Biondi Martin Schrappe

The Associazione Italiana di Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster Acute Lymphoblastic Leukemia (AIEOP-BFM ALL 2000) study has for the first time introduced standardized quantitative assessment of minimal residual disease (MRD) based on immunoglobulin and T-cell receptor gene rearrangements as polymerase chain reaction targets (PCR-MRD), at 2 time points (TPs), to str...

Journal: :Blood 2015
Michael A Pulsipher Chris Carlson Bryan Langholz Donna A Wall Kirk R Schultz Nancy Bunin Ilan Kirsch Julie M Gastier-Foster Michael Borowitz Cindy Desmarais David Williamson Michael Kalos Stephan A Grupp

Positive detection of minimal residual disease (MRD) by multichannel flow cytometry (MFC) prior to hematopoietic cell transplantation (HCT) of patients with acute lymphoblastic leukemia (ALL) identifies patients at high risk for relapse, but many pre-HCT MFC-MRD negative patients also relapse, and the predictive power MFC-MRD early post-HCT is poor. To test whether the increased sensitivity of ...

2018
Giovanni Cazzaniga Paola De Lorenzo Julia Alten Silja Röttgers Jeremy Hancock Vaskar Saha Anders Castor Hans O. Madsen Virginie Gandemer Hélène Cavé Veronica Leoni Rolf Köhler Giulia M. Ferrari Kirsten Bleckmann Rob Pieters Vincent van der Velden Jan Stary Jan Zuna Gabriele Escherich Udo zur Stadt Maurizio Aricò Valentino Conter Martin Schrappe Maria Grazia Valsecchi Andrea Biondi

The prognostic value of minimal residual disease (MRD) in Philadelphia-chromosome-positive (Ph+) childhood acute lymphoblastic leukemia (ALL) treated with tyrosine kinase inhibitors is not fully established. We detected MRD by real-time quantitative polymerase chain reaction (RQ-PCR) of rearranged immunoglobulin/T-cell receptor genes (IG/TR) and/or BCR/ABL1 fusion transcript to investigate its ...

Journal: :Indian pediatrics 2016
Karthik Bommannan Man Updesh Singh Sachdeva Neelam Varma Parveen Bose Deepak Bansal

OBJECTIVE To study the role of mid-induction (day 15) peripheral blood minimal residual disease (PB-MRD) detection in pediatric B- lineage acute lymphoblastic leukemia (B-ALL). DESIGN Prospective. SETTING Tertiary-care center. PATIENTS 40 consecutively-diagnosed treatment-naive, pediatric B-ALL patients. INTERVENTION National Cancer Institute (NCI) standard risk patients were given thre...

Journal: :Cytometry. Part B, Clinical cytometry 2015
Joseph A DiGiuseppe Michelle D Tadmor Dana Pe'er

BACKGROUND Minimal residual disease (MRD) following treatment is a robust prognostic marker in B lymphoblastic leukemia. However, the detection of MRD by flow cytometric immunophenotyping is technically challenging, and an automated method to detect MRD is therefore desirable. viSNE, a recently developed computational tool based on the t-Distributed Stochastic Neighbor Embedding (t-SNE) algorit...

2015
Jitsuda Sitthi-amorn Betty Herrington Gail Megason Jeanette Pullen Catherine Gordon Shirley Hogan Tejaswi Koganti Chindo Hicks

Acute lymphoblastic leukemia (ALL) is the most common childhood cancer and the leading cause of cancer-related death in children and adolescents. Minimal residual disease (MRD) is a strong, independent prognostic factor. The objective of this study was to identify molecular signatures distinguishing patients with positive MRD from those with negative MRD in different subtypes of ALL, and to ide...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید